These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37292146)

  • 1. Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds.
    Ahmed IA; Hafiz S; van Ginkel S; Pondugula SR; Abdelhaffez AS; Sayyed HG; El-Aziz EAA; Mansour MM
    Nat Prod Commun; 2023 May; 18(5):. PubMed ID: 37292146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
    Pilling A; Kim SH; Hwang C
    Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
    Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
    Tamaki H; Harashima N; Hiraki M; Arichi N; Nishimura N; Shiina H; Naora K; Harada M
    Oncotarget; 2014 Nov; 5(22):11399-412. PubMed ID: 25333266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.
    Zhu S; Oremo JA; Li S; Zhen M; Tang Y; Du Y
    PLoS One; 2014; 9(3):e91817. PubMed ID: 24632829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer.
    Lima TS; Souza LO; Iglesias-Gato D; Elversang J; Jørgensen FS; Kallunki T; Røder MA; Brasso K; Moreira JMA
    Front Pharmacol; 2022; 13():869461. PubMed ID: 35721223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a docetaxel-resistant human prostate cancer cell line.
    Liu J; Huang Y; Zhu D; Dai Y; Liu D; Zhai Y; Liang X; Wu L; Zhao Q
    Oncol Lett; 2020 Nov; 20(5):230. PubMed ID: 32968452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer.
    Li YF; Ji HH; Zhang ZL; Zhang TT; Gan W; Zhang SF
    Oncol Lett; 2017 Aug; 14(2):1748-1756. PubMed ID: 28789405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.
    Sato A; Itcho N; Ishiguro H; Okamoto D; Kobayashi N; Kawai K; Kasai H; Kurioka D; Uemura H; Kubota Y; Watanabe M
    Int J Nanomedicine; 2013; 8():3151-60. PubMed ID: 23990723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells.
    Inamura SO; Ito H; Taga M; Tsuchiyama K; Hoshino H; Kobayashi M; Yokoyama O
    Anticancer Res; 2019 Oct; 39(10):5417-5425. PubMed ID: 31570436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line.
    Cancino-Marentes ME; Hernández-Flores G; Ortiz-Lazareno PC; Villaseñor-García MM; Orozco-Alonso E; Sierra-Díaz E; Solís-Martínez RA; Cruz-Gálvez CC; Bravo-Cuellar A
    BMC Urol; 2021 Mar; 21(1):38. PubMed ID: 33711972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer.
    Mao L; Yu H; Ma S; Xu Z; Wei F; Yang C; Zheng J
    J Cancer; 2021; 12(6):1846-1852. PubMed ID: 33613773
    [No Abstract]   [Full Text] [Related]  

  • 15. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway.
    Singh SK; Apata T; Gordetsky JB; Singh R
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.
    Varol U; Degirmenci M; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Sanli UA; Uslu R
    Tumour Biol; 2015 Feb; 36(2):779-86. PubMed ID: 25293519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
    Lian H; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells.
    Mansour M; van Ginkel S; Dennis JC; Mason B; Elhussin I; Abbott K; Pondugula SR; Samuel T; Morrison E
    J Cancer; 2018; 9(23):4536-4546. PubMed ID: 30519360
    [No Abstract]   [Full Text] [Related]  

  • 19. 4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells.
    da Silva Guimarães G; Cordeiro AO; Gazolla MC; Vecchi L; Pereira Zoia MA; de Vasconcelos Azevedo FVP; Moreira Campos I; de Souza Costa D; Soares Mota ST; Alves Ribeiro M; Goulart LR; da Silva Filho AA; Araújo TG
    Curr Top Med Chem; 2023; 23(11):943-955. PubMed ID: 36748811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
    Mathur A; Abd Elmageed ZY; Liu X; Kostochka ML; Zhang H; Abdel-Mageed AB; Mondal D
    PLoS One; 2014; 9(8):e103109. PubMed ID: 25121735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.